|
PART 1 Pharmacology Basics |
|
|
1 | (148) |
|
Study Skills Tips: Introduction to Study Skills Concepts, PURR, and Pharmacology Basics |
|
|
|
The Nursing Process and Drug Therapy |
|
|
6 | (8) |
|
Overview of the Nursing Process |
|
|
6 | (1) |
|
|
|
7 | (2) |
|
|
|
9 | (1) |
|
|
|
9 | (1) |
|
|
|
10 | (4) |
|
|
|
14 | (1) |
|
|
|
14 | (22) |
|
|
|
17 | (2) |
|
|
|
19 | (1) |
|
|
|
20 | (8) |
|
|
|
28 | (1) |
|
|
|
29 | (4) |
|
|
|
33 | (1) |
|
|
|
33 | (1) |
|
|
|
34 | (1) |
|
|
|
34 | (2) |
|
|
|
36 | (13) |
|
Drug Therapy During Pregnancy |
|
|
36 | (1) |
|
Drug Therapy During Breast-Feeding |
|
|
37 | (1) |
|
Considerations For Neonatal And Pediatric Patients |
|
|
37 | (3) |
|
Considerations For Elderly Patients |
|
|
40 | (4) |
|
|
|
44 | (5) |
|
Cultural, Legal, and Ethical Considerations |
|
|
49 | (12) |
|
|
|
50 | (2) |
|
U.S Drug and Related Legislation |
|
|
52 | (1) |
|
|
|
52 | (3) |
|
Cultural, Legal, and Ethical Considerations For Nursing Practice |
|
|
55 | (3) |
|
|
|
58 | (3) |
|
Gene Therapy and Pharmacogenetics |
|
|
61 | (8) |
|
Basic Prinicples of Genetic Inheritance |
|
|
62 | (1) |
|
Discrovery, Structure, And Function of DNA |
|
|
62 | (2) |
|
|
|
64 | (1) |
|
Pharmacogenetics and Pharmacogenomics |
|
|
65 | (1) |
|
Application of Genetic Principles Related to Drug Therapy and the Nursing Process |
|
|
66 | (1) |
|
|
|
67 | (2) |
|
Medication Errors: Preventing and Responding |
|
|
69 | (9) |
|
General Impact of Errors on Patients |
|
|
69 | (1) |
|
|
|
69 | (2) |
|
Psychosocial Issues That Contribute to Errors |
|
|
71 | (3) |
|
Preventing, Responding to, Reporting and Documenting Medication Errors: A Nursing Perspective |
|
|
74 | (2) |
|
|
|
76 | (1) |
|
|
|
76 | (2) |
|
Patient Education and Drug Therapy |
|
|
78 | (9) |
|
Assessment of Learning Needs Related to Drug Therapy |
|
|
79 | (1) |
|
Nursing Diagnoses Related to Learning Needs and Drug Therapy |
|
|
80 | (1) |
|
Planning Related to Learning Needs and Drug Therapy |
|
|
80 | (1) |
|
Implementation Related to Patient Education and Drug Therapy |
|
|
81 | (3) |
|
Evaluation of Patient Learning Related to Drug Therapy |
|
|
84 | (1) |
|
|
|
84 | (3) |
|
Over-the-Counter Drugs and Herbal and Dietary Supplements |
|
|
87 | (10) |
|
|
|
87 | (3) |
|
Herbals And Dietary Supplements |
|
|
90 | (3) |
|
|
|
93 | (4) |
|
|
|
97 | (15) |
|
Anatomy, Physiology, and Disease Overview |
|
|
97 | (1) |
|
|
|
98 | (1) |
|
|
|
98 | (1) |
|
|
|
99 | (2) |
|
|
|
101 | (1) |
|
|
|
102 | (2) |
|
|
|
104 | (1) |
|
|
|
105 | (7) |
|
Photo Atlas of Drug Administration |
|
|
112 | (37) |
|
Preparing For Drug Administraton |
|
|
112 | (2) |
|
|
|
114 | (6) |
|
|
|
120 | (18) |
|
|
|
138 | (11) |
|
PART 2 Drugs Affecting the Central Nervous System |
|
|
149 | (137) |
|
Study Skills Tips: Vocabulary, Text Notation, and Language Conventions |
|
|
|
|
|
151 | (27) |
|
Anatomy, Physiology, and Disease Overview |
|
|
97 | (59) |
|
Treatment of Pain in Special Situations |
|
|
156 | (2) |
|
|
|
158 | (1) |
|
|
|
158 | (7) |
|
Nonopioid and Miscellaneous Analgesics |
|
|
165 | (2) |
|
|
|
167 | (11) |
|
General and Local Anesthetics |
|
|
178 | (18) |
|
Anatomy, Physiology, and Disease Overview |
|
|
178 | (1) |
|
|
|
179 | (1) |
|
|
|
179 | (3) |
|
Drugs For Moderate Sedation |
|
|
182 | (1) |
|
|
|
182 | (4) |
|
Neromuscular Blocking Drugs |
|
|
186 | (3) |
|
|
|
189 | (7) |
|
Central Nervous System Depressants and Muscle Relaxants |
|
|
196 | (56) |
|
Anatomy, Physiology, and Disease Overview |
|
|
197 | (1) |
|
|
|
197 | (1) |
|
|
|
197 | (1) |
|
Benzodiazepines and Miscellaneous Hypnotic Drugs |
|
|
197 | (4) |
|
|
|
201 | (2) |
|
|
|
203 | (2) |
|
|
|
205 | (47) |
|
Central Nervous System Stimulants and Related Drugs |
|
|
252 | |
|
Anatomy, Physiology, and Disease Overview |
|
|
210 | (1) |
|
Attention Deficit Hyperactivity Disorder |
|
|
211 | (1) |
|
|
|
211 | (43) |
|
Drugs For Attention Deficit Hyperactivity and Narcolepsy |
|
|
254 | |
|
|
|
212 | (1) |
|
|
|
212 | (1) |
|
Analeptic-Respnsive Respiratory Depression Syndromes |
|
|
212 | |
|
|
|
197 | (15) |
|
Drugs For Attention Deficit Hyperactivity Disorder and Narcolepsy |
|
|
212 | (3) |
|
|
|
215 | (2) |
|
|
|
217 | (2) |
|
Drugs For Specific Respiratory Depression Syndromes: Analeptics |
|
|
219 | (1) |
|
|
|
220 | (6) |
|
|
|
226 | (18) |
|
Anatomy, Physiology, and Disease Overview |
|
|
226 | (1) |
|
|
|
226 | (2) |
|
|
|
228 | (1) |
|
|
|
228 | (10) |
|
|
|
238 | (6) |
|
|
|
244 | (16) |
|
Anatomy, Physiology, and Disease Overview |
|
|
244 | (1) |
|
|
|
244 | (2) |
|
|
|
246 | (1) |
|
Indirect-Acting Dopaminergic Drugs |
|
|
246 | (1) |
|
Monoamine Oxidase Inhibitors |
|
|
246 | (4) |
|
Presynaptic Dopamine Release Enhancer |
|
|
250 | (1) |
|
Catechol Ortho-Methyltransferase Inhibitors |
|
|
250 | (1) |
|
Direct-Acting Dopamine Receptor Agonists |
|
|
251 | (1) |
|
Nondopamine Dopamine Receptor Agonists |
|
|
251 | (1) |
|
Dopamine Replacement Drugs |
|
|
252 | |
|
|
|
216 | (1) |
|
|
|
217 | (43) |
|
|
|
260 | (26) |
|
Anatomy, Physiology, and Disease Overview |
|
|
261 | (1) |
|
|
|
262 | (1) |
|
|
|
262 | (6) |
|
Drugs Used to Treat Affective Disorders |
|
|
268 | (1) |
|
|
|
268 | (1) |
|
|
|
268 | (2) |
|
Tricyclic Antidepressants |
|
|
270 | (1) |
|
Monoamine Oxidase Inhibitors |
|
|
271 | (1) |
|
Newer Generation Antidepressants |
|
|
272 | (2) |
|
|
|
274 | (3) |
|
|
|
277 | (9) |
|
PART 3 Drugs Affecting the Autonomic Nervous System |
|
|
286 | (45) |
|
Study Skills Tips: PURR Application and Study Groups |
|
|
|
|
|
288 | (13) |
|
Anatomy and Physilogy Overview |
|
|
289 | (1) |
|
Sympathetic Nervous System |
|
|
289 | (2) |
|
|
|
291 | (1) |
|
|
|
291 | (4) |
|
|
|
295 | (6) |
|
Adrenergic-Blocking Drugs |
|
|
301 | (11) |
|
Anatomy and Physiology Overview |
|
|
301 | (1) |
|
|
|
302 | (1) |
|
|
|
302 | (2) |
|
|
|
304 | (4) |
|
|
|
308 | (4) |
|
|
|
312 | (10) |
|
Anatomy and Physiology Overview |
|
|
312 | (1) |
|
Parasympathetic Nervous System |
|
|
312 | (1) |
|
|
|
312 | (1) |
|
|
|
312 | (5) |
|
|
|
317 | (5) |
|
Cholinergic-Blocking Drugs |
|
|
322 | (9) |
|
Anatomy and Physilogy Overview |
|
|
322 | (1) |
|
Parasympathetic Nervous System |
|
|
322 | (1) |
|
|
|
322 | (1) |
|
Cholinergic-Blocking Drugs |
|
|
322 | (5) |
|
|
|
327 | (4) |
|
PART 4 Drugs Affecting the Cardiovascular and Renal Systems |
|
|
331 | (139) |
|
Study Skills Tips: Linking Learning and Text Notation |
|
|
|
|
|
334 | (13) |
|
Anatomy, Physiology, and Disease Overview |
|
|
334 | (1) |
|
|
|
335 | (1) |
|
Angiotensin-Converting Enzyme Inhibitors |
|
|
336 | (1) |
|
Angiotensin II Receptor Blockers |
|
|
336 | (1) |
|
|
|
337 | (1) |
|
Miscellaneous Heart Failure Drugs |
|
|
337 | (1) |
|
B-Type Natriuretic Peptide |
|
|
337 | (1) |
|
Phosphodiesterase Inhibitors |
|
|
337 | (2) |
|
|
|
339 | (3) |
|
|
|
342 | (5) |
|
|
|
347 | (21) |
|
Anatomy, Physiology, and Disease Overview |
|
|
348 | (1) |
|
Dysrhythmias and Normal Cardiac Electrophysiology |
|
|
348 | (6) |
|
|
|
354 | (1) |
|
|
|
354 | (10) |
|
|
|
364 | (4) |
|
|
|
368 | (14) |
|
Anatomy, Physiology, and Disease Overview |
|
|
368 | (1) |
|
|
|
369 | (1) |
|
|
|
369 | (2) |
|
|
|
371 | (2) |
|
|
|
373 | (2) |
|
Miscellenous Antianginal Drug |
|
|
375 | (1) |
|
Summary of Antianginal Pharmacology |
|
|
375 | (1) |
|
|
|
376 | (6) |
|
|
|
382 | (21) |
|
Anatomy, Physiology, and Disease Overview |
|
|
382 | (1) |
|
|
|
383 | (1) |
|
|
|
383 | (1) |
|
Review of Autonomic Neurotransmission |
|
|
384 | (1) |
|
|
|
384 | (5) |
|
Angiotensin-Converting Enzyme Inhibitors |
|
|
389 | (2) |
|
Angiotensin II Receptor Blockers |
|
|
391 | (1) |
|
|
|
392 | (1) |
|
|
|
392 | (1) |
|
|
|
392 | (2) |
|
Miscellaneous Antihypertensive Drugs |
|
|
394 | (1) |
|
|
|
395 | (8) |
|
|
|
403 | (14) |
|
Anatomy and Physilogy Overview |
|
|
403 | (1) |
|
|
|
404 | (1) |
|
Carbonic Anhydrase Inhibitors |
|
|
404 | (2) |
|
|
|
406 | (1) |
|
|
|
407 | (2) |
|
Potassium-Sparing Diuretics |
|
|
409 | (1) |
|
Thiazides And Thiazide-Like Diuretics |
|
|
410 | (2) |
|
|
|
412 | (5) |
|
|
|
417 | (15) |
|
Anatomy, Physiology, and Disease Overview |
|
|
418 | (1) |
|
|
|
419 | (1) |
|
|
|
419 | (2) |
|
|
|
421 | (1) |
|
|
|
422 | (1) |
|
Physiology of Electrolyte Balance |
|
|
423 | (1) |
|
|
|
423 | (2) |
|
|
|
425 | (1) |
|
|
|
426 | (6) |
|
Coagulation Modifier Drugs |
|
|
432 | (23) |
|
Anatomy, Physiology, and Disease Overview |
|
|
433 | (1) |
|
|
|
434 | (2) |
|
|
|
436 | (4) |
|
|
|
440 | (3) |
|
|
|
443 | (1) |
|
|
|
444 | (2) |
|
|
|
446 | (9) |
|
|
|
455 | (15) |
|
Anatomy, Physiology, and Disease Overview |
|
|
455 | (1) |
|
Lipids And Lipid Abnormalities |
|
|
456 | (1) |
|
Atherosclerotic Plaque Formation |
|
|
457 | (1) |
|
Link Between Cholesterol and Coronary Heart Disease |
|
|
457 | (1) |
|
Hyperlipidemias and Treatment Guidelines |
|
|
458 | (1) |
|
|
|
459 | (1) |
|
Hydroxymethylglutaryl-Coenzyme A Reductase Inhibitors |
|
|
459 | (2) |
|
|
|
461 | (1) |
|
|
|
462 | (1) |
|
Fibric Acid Derivatives and Cholesterol Absorption Inhibitor |
|
|
463 | (2) |
|
|
|
465 | (5) |
|
PART 5 Drugs Affecting the Endocrine Systems |
|
|
470 | (79) |
|
Study Skills Tips: Questioning Strategy |
|
|
|
|
|
472 | (8) |
|
Anatomy and Physiology Overview |
|
|
472 | (1) |
|
|
|
472 | (1) |
|
|
|
473 | (1) |
|
|
|
473 | (2) |
|
|
|
475 | (5) |
|
Thyroid and Antithyroid Drugs |
|
|
480 | (8) |
|
Anatomy, Physiology, and Disease Overview |
|
|
480 | (1) |
|
|
|
480 | (1) |
|
|
|
481 | (1) |
|
|
|
481 | (1) |
|
Thyroid Replacement Drugs |
|
|
481 | (1) |
|
|
|
482 | (1) |
|
|
|
482 | (1) |
|
|
|
482 | (1) |
|
|
|
482 | (2) |
|
|
|
484 | (4) |
|
|
|
488 | (21) |
|
Anatomy, Physiology, and Disease Overview |
|
|
489 | (1) |
|
|
|
489 | (1) |
|
|
|
489 | (4) |
|
|
|
493 | (1) |
|
|
|
493 | (1) |
|
|
|
493 | (4) |
|
Traditional Oral Drugs for Diabetes |
|
|
497 | (1) |
|
|
|
497 | (1) |
|
|
|
498 | (1) |
|
|
|
498 | (1) |
|
|
|
499 | (1) |
|
Alpha-Glucosidase Inhibitors |
|
|
499 | (1) |
|
|
|
500 | (1) |
|
|
|
500 | (1) |
|
|
|
501 | (1) |
|
|
|
501 | (1) |
|
|
|
501 | (1) |
|
|
|
502 | (7) |
|
|
|
509 | (10) |
|
Anatomy, Physiology, and Disease Overview |
|
|
509 | (1) |
|
|
|
509 | (2) |
|
|
|
511 | (1) |
|
|
|
511 | (3) |
|
|
|
514 | (5) |
|
|
|
519 | (21) |
|
Anatomy and Physiology Overview |
|
|
520 | (1) |
|
Female Reproductive Functions |
|
|
520 | |
|
|
|
511 | (10) |
|
|
|
521 | (4) |
|
|
|
521 | (3) |
|
|
|
524 | (1) |
|
|
|
525 | (2) |
|
|
|
527 | (2) |
|
Drugs Related to Pregnancy, Labor, Delivery, and the Postpartum Period |
|
|
529 | (1) |
|
|
|
529 | (1) |
|
|
|
530 | (4) |
|
|
|
534 | (6) |
|
|
|
540 | (9) |
|
Anatomy and Physiology Overview |
|
|
540 | (1) |
|
|
|
540 | (1) |
|
|
|
541 | (1) |
|
Androgens and Other Drugs Pertaining to Men's Health |
|
|
541 | (4) |
|
|
|
545 | (4) |
|
PART 6 Drugs Affecting the Respiratory System |
|
|
549 | (33) |
|
Study Skills Tips: Study on the Run and PURR |
|
|
|
Antihistamines, Decongestants, Antitussives, and Expectorants |
|
|
551 | (13) |
|
Anatomy, Physiology, and Disease Overview |
|
|
552 | (1) |
|
|
|
552 | (1) |
|
|
|
552 | (4) |
|
|
|
556 | (2) |
|
|
|
558 | (1) |
|
|
|
559 | (1) |
|
|
|
560 | (4) |
|
Bronchodilators and Other Respiratory Drugs |
|
|
564 | (18) |
|
Anatomy, Physiology, and Disease Overview |
|
|
565 | (1) |
|
Diseases of the Respiratory System |
|
|
565 | (1) |
|
Treatment of Diseases of the Lower Respiratory Tract |
|
|
566 | (1) |
|
|
|
566 | (1) |
|
|
|
566 | (2) |
|
|
|
568 | (1) |
|
|
|
569 | (1) |
|
|
|
570 | (1) |
|
Nonbronchodilating Respiratory Drugs |
|
|
571 | (1) |
|
Leukotriene Receptor Antagonists |
|
|
572 | (1) |
|
|
|
572 | (3) |
|
Monoclonal Antibody Antiasthmatic |
|
|
575 | (1) |
|
|
|
575 | (7) |
|
PART 7 Antinfective and Antiinflammatory Drugs |
|
|
582 | (110) |
|
Study Sills Tips: Applying the Nursing Process |
|
|
|
|
|
584 | (23) |
|
Anatomy, Physiology, and Disease Overview |
|
|
585 | (1) |
|
|
|
585 | (1) |
|
|
|
586 | (2) |
|
|
|
588 | (1) |
|
|
|
589 | (1) |
|
|
|
590 | (1) |
|
|
|
591 | (3) |
|
|
|
594 | (3) |
|
|
|
597 | |
|
|
|
584 | (14) |
|
|
|
598 | (2) |
|
|
|
600 | (1) |
|
|
|
600 | (2) |
|
|
|
602 | (5) |
|
|
|
607 | (16) |
|
|
|
608 | (1) |
|
|
|
608 | (1) |
|
|
|
608 | (3) |
|
|
|
611 | (2) |
|
Miscellaneous Antibiotics |
|
|
613 | (3) |
|
|
|
616 | (7) |
|
|
|
623 | (22) |
|
Anatomy, Physiology, and Disease Overview |
|
|
624 | (1) |
|
General Prinicples of Virology |
|
|
624 | (1) |
|
Overview of Viral Illnesses And Their Treatment |
|
|
625 | (1) |
|
Herpes Simplex Virus and Varicella-Zoster Virus Infections |
|
|
626 | (1) |
|
Pharmacology Overview of Antivirals (non-HIV) |
|
|
627 | (4) |
|
Disease Overview of HIV Infection and AIDS |
|
|
631 | (4) |
|
Pharmacology Overview of Drugs Used to Treat HIV Infection |
|
|
635 | (4) |
|
Disease Overview of Other Viral Infections |
|
|
639 | (1) |
|
|
|
639 | (6) |
|
|
|
645 | (10) |
|
Anatomy, Physiology, and Disease Overview |
|
|
645 | (1) |
|
|
|
645 | (1) |
|
|
|
646 | (1) |
|
|
|
646 | (5) |
|
|
|
651 | (4) |
|
|
|
655 | (9) |
|
Anatomy, Physiology, and Disease Overview |
|
|
655 | (1) |
|
|
|
655 | (1) |
|
|
|
656 | (1) |
|
|
|
656 | (5) |
|
|
|
661 | (3) |
|
Antimalarial, Antiprotozoal, and Anthelmintic Drugs |
|
|
664 | (14) |
|
Anatomy, Physiology, and Disease Overview |
|
|
664 | (1) |
|
|
|
664 | (1) |
|
|
|
665 | (1) |
|
|
|
665 | (3) |
|
Other Protozoal Infections |
|
|
668 | (1) |
|
|
|
669 | (2) |
|
|
|
671 | (1) |
|
|
|
672 | (2) |
|
|
|
674 | (4) |
|
Antinflammatory and Antigout Drugs |
|
|
678 | (14) |
|
Anatomy, Physiology, and Disease Overview |
|
|
678 | (1) |
|
|
|
679 | (1) |
|
Nonsteroidal Antiinflammatory Drugs |
|
|
679 | (6) |
|
|
|
685 | (2) |
|
|
|
687 | (5) |
|
PART 8 Immune and Biologic Modifiers and Chemotherapeutic Drugs |
|
|
692 | (90) |
|
Study Skills Tips: Manage Time, Evaluate Prior Performance, Anticipate the Test, and Plan for Distributed Study |
|
|
|
|
|
694 | (10) |
|
Anatomy, Physiology, and Diseaese Overview |
|
|
694 | (1) |
|
|
|
694 | (1) |
|
|
|
694 | (1) |
|
|
|
694 | (6) |
|
|
|
700 | (4) |
|
Immunizing Drugs and Biochemical Terrorism |
|
|
704 | (17) |
|
Anatomy, Physiology, and Disease Overview |
|
|
705 | (1) |
|
Immunity And Immunization |
|
|
705 | (3) |
|
|
|
708 | (1) |
|
|
|
708 | (8) |
|
Biologic and Chemical Terrorism |
|
|
716 | (1) |
|
|
|
716 | (1) |
|
|
|
717 | (4) |
|
Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle-Specific Drugs |
|
|
721 | (26) |
|
Anatomy, Physiology, and Disease Overview |
|
|
722 | (2) |
|
|
|
724 | (2) |
|
|
|
726 | (1) |
|
|
|
726 | (1) |
|
|
|
727 | (3) |
|
Cell Cycle-Specific Antineoplastic Drugs |
|
|
730 | (1) |
|
|
|
730 | (3) |
|
|
|
733 | (2) |
|
Alkaloid Topoisomerase II Inhibitors |
|
|
735 | (1) |
|
Topoisomerase II Inhibitors |
|
|
736 | (1) |
|
|
|
737 | (1) |
|
|
|
738 | (9) |
|
Antineoplastic Drugs Part 2: Cell Cycle-Nonspecific Drugs and Miscellaneous Drugs |
|
|
747 | (14) |
|
|
|
748 | (1) |
|
Cell Cycle-Nonspecific Antineoplastic Drugs |
|
|
748 | (1) |
|
|
|
748 | (3) |
|
|
|
751 | (1) |
|
Miscellaneous Antineoplastics |
|
|
752 | (2) |
|
|
|
754 | (1) |
|
Radiopharmaceuticals and Related Antineoplastics |
|
|
754 | (1) |
|
Cytoprotective Drugs and Miscellaneous Toxicity Inhibitors |
|
|
755 | (1) |
|
|
|
755 | (6) |
|
Biologic Response ---Modifying and Antirtheumatoid Drugs |
|
|
761 | (21) |
|
Anatomy, Physiology, and Disease Overview |
|
|
762 | (1) |
|
Overview of Immunodulators |
|
|
763 | (1) |
|
|
|
763 | (1) |
|
|
|
764 | (1) |
|
|
|
764 | (3) |
|
|
|
767 | (2) |
|
|
|
769 | (4) |
|
Interleukins and Related Drugs |
|
|
773 | (1) |
|
Miscellaneous Immunomodulating Drugs |
|
|
774 | (1) |
|
|
|
774 | (1) |
|
Disease-Modifying Antirheumatoid Arthritis Drugs |
|
|
775 | (2) |
|
|
|
777 | (5) |
|
PART 9 Drugs Affecting the Gastrointestinal System and Nutrition |
|
|
782 | (70) |
|
Study Skills Tips: Active Questioning, What Are the Right Questions, Kinds of Questions, and Questioning Application |
|
|
|
|
|
784 | (13) |
|
Anatomy, Physiology, and Disease Overview |
|
|
784 | (1) |
|
Acid-Related Pathophysiology |
|
|
784 | (3) |
|
|
|
787 | (1) |
|
|
|
787 | (1) |
|
|
|
788 | (3) |
|
|
|
791 | (1) |
|
Miscellaneous Acid-Controlling Drugs |
|
|
792 | (1) |
|
|
|
793 | (4) |
|
|
|
797 | (13) |
|
Anatomy, Physiology, and Disease Overview |
|
|
797 | (1) |
|
|
|
797 | (1) |
|
|
|
797 | (3) |
|
|
|
800 | (6) |
|
Drugs for Irritable Bowel Syndrome |
|
|
806 | (1) |
|
|
|
806 | (4) |
|
Antiemetic and Antinausea Drugs |
|
|
810 | (11) |
|
Anatomy, Physiology, and Disease Overview |
|
|
810 | (1) |
|
|
|
810 | (1) |
|
|
|
810 | (1) |
|
|
|
810 | (6) |
|
|
|
816 | (5) |
|
|
|
821 | (20) |
|
Physiology and Disease Overview |
|
|
821 | (1) |
|
|
|
822 | (1) |
|
|
|
822 | (1) |
|
|
|
823 | (1) |
|
|
|
823 | (1) |
|
|
|
824 | (3) |
|
|
|
827 | (1) |
|
|
|
828 | (5) |
|
|
|
833 | |
|
|
|
829 | (1) |
|
|
|
829 | (1) |
|
|
|
830 | (1) |
|
|
|
831 | (1) |
|
|
|
832 | (1) |
|
|
|
833 | (1) |
|
|
|
834 | (1) |
|
|
|
834 | (2) |
|
|
|
836 | (1) |
|
|
|
836 | (1) |
|
|
|
837 | (1) |
|
|
|
837 | (4) |
|
|
|
841 | (11) |
|
Anatomy, Physiology, and Disease Overview |
|
|
842 | (1) |
|
|
|
842 | (1) |
|
|
|
842 | (2) |
|
|
|
844 | (1) |
|
Peripheral Total Parenteral Nutrition |
|
|
845 | (1) |
|
|
|
846 | (1) |
|
Central Total Parenteral Nutrition |
|
|
847 | (1) |
|
|
|
847 | (5) |
|
PART 10 Miscellaneous Therapeutics: Hematologic, Dermatologic, Ophthalmic, and Otic Drugs |
|
|
852 | (53) |
|
Study Skills Tips: Time Management, PURR, and Repeat the Steps |
|
|
|
|
|
854 | (9) |
|
Anatomy, Physiology, and Disease Overview |
|
|
854 | (1) |
|
|
|
854 | (1) |
|
|
|
855 | (2) |
|
|
|
857 | (1) |
|
|
|
857 | (2) |
|
|
|
859 | (1) |
|
|
|
860 | (1) |
|
|
|
860 | (3) |
|
|
|
863 | (13) |
|
Anatomy, Physiology, and Disease Overview |
|
|
864 | (1) |
|
|
|
865 | (1) |
|
|
|
865 | (1) |
|
General Antibacterial Drugs |
|
|
865 | (1) |
|
|
|
866 | (1) |
|
|
|
867 | (1) |
|
|
|
868 | (1) |
|
Anesthetic, Antipruritic, and Antipsoriatic Drugs |
|
|
869 | (1) |
|
|
|
869 | (1) |
|
Topical Antipruritics and Antinflammatories |
|
|
869 | (1) |
|
|
|
870 | (1) |
|
Miscellaneous Dermatologic Drugs |
|
|
870 | (2) |
|
|
|
872 | (1) |
|
|
|
873 | (1) |
|
|
|
873 | (3) |
|
|
|
876 | (23) |
|
|
|
877 | (1) |
|
|
|
878 | (1) |
|
|
|
878 | (2) |
|
|
|
880 | (1) |
|
|
|
880 | (1) |
|
|
|
881 | (2) |
|
|
|
883 | (2) |
|
|
|
885 | (1) |
|
Carbonic Anhydrase Inhibitors |
|
|
886 | (1) |
|
|
|
887 | (1) |
|
|
|
888 | (1) |
|
|
|
889 | (3) |
|
|
|
892 | (1) |
|
|
|
893 | (1) |
|
|
|
894 | (1) |
|
|
|
894 | (1) |
|
|
|
895 | (4) |
|
|
|
899 | (6) |
|
Anatomy, Physiology, and Disease Overview |
|
|
899 | (1) |
|
|
|
900 | (1) |
|
Treatment of Ear Disorders |
|
|
900 | (1) |
|
Antibacterial and Antifungal Otic Drugs |
|
|
900 | (1) |
|
|
|
901 | (4) |
| Appendix Pharmaceutical Abbreviations |
|
905 | (1) |
| Bibliography |
|
906 | (16) |
| Index |
|
922 | |
